These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
340 related items for PubMed ID: 28102845
1. H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Peng F, Li TT, Wang KL, Xiao GQ, Wang JH, Zhao HD, Kang ZJ, Fan WJ, Zhu LL, Li M, Cui B, Zheng FM, Wang HJ, Lam EW, Wang B, Xu J, Liu Q. Cell Death Dis; 2017 Jan 19; 8(1):e2569. PubMed ID: 28102845 [Abstract] [Full Text] [Related]
4. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma. Li M, Chai HF, Peng F, Meng YT, Zhang LZ, Zhang L, Zou H, Liang QL, Li MM, Mao KG, Sun DX, Tong MY, Deng ZQ, Hou ZJ, Zhao Y, Li J, Wang XC, Lv SS, Zhang QQ, Yu X, Lam EW, Liu Q, Cui XN, Xu J. Cell Death Dis; 2018 Nov 02; 9(11):1120. PubMed ID: 30389909 [Abstract] [Full Text] [Related]
5. H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells. Wang M, Li Y, Xiao GD, Zheng XQ, Wang JC, Xu CW, Qin S, Ren H, Tang SC, Sun X. Cell Prolif; 2019 Jan 02; 52(1):e12534. PubMed ID: 30338598 [Abstract] [Full Text] [Related]
8. MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Sun X, Jiang S, Liu J, Wang H, Zhang Y, Tang SC, Wang J, Du N, Xu C, Wang C, Qin S, Zhang J, Liu D, Zhang Y, Li X, Wang J, Dong J, Wang X, Xu S, Tao Z, Xu F, Zhou J, Wang T, Ren H. Oncotarget; 2015 Oct 20; 6(32):32944-54. PubMed ID: 26460550 [Abstract] [Full Text] [Related]
10. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway. Han L, Yan Y, Zhao L, Liu Y, Lv X, Zhang L, Zhao Y, Zhao H, He M, Wei M. J Cell Mol Med; 2020 Jun 20; 24(11):6242-6252. PubMed ID: 32307830 [Abstract] [Full Text] [Related]
11. MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7. Liang R, Li Y, Wang M, Tang SC, Xiao G, Sun X, Li G, Du N, Liu D, Ren H. Cell Cycle; 2018 Jun 20; 17(12):1445-1456. PubMed ID: 29954239 [Abstract] [Full Text] [Related]
12. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties. Liu S, Sun Y, Hou Y, Yang L, Wan X, Qin Y, Liu Y, Wang R, Zhu P, Teng Y, Liu M. J Hematol Oncol; 2021 Oct 29; 14(1):178. PubMed ID: 34715882 [Abstract] [Full Text] [Related]
13. LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling. Tang T, Guo C, Xia T, Zhang R, Zen K, Pan Y, Jin L. Theranostics; 2019 Oct 29; 9(24):7384-7402. PubMed ID: 31695775 [Abstract] [Full Text] [Related]
16. Oncofetal H19 RNA promotes tumor metastasis. Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, Richler C, Fellig Y, Sorin V, Hubert A, Hochberg A, Czerniak A. Biochim Biophys Acta; 2014 Jul 29; 1843(7):1414-26. PubMed ID: 24703882 [Abstract] [Full Text] [Related]
17. CAIX-Mediated Control of LIN28/let-7 Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia. Gibadulinova A, Bullova P, Strnad H, Pohlodek K, Jurkovicova D, Takacova M, Pastorekova S, Svastova E. Int J Mol Sci; 2020 Jun 16; 21(12):. PubMed ID: 32560271 [Abstract] [Full Text] [Related]
19. LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Murray MJ, Saini HK, Siegler CA, Hanning JE, Barker EM, van Dongen S, Ward DM, Raby KL, Groves IJ, Scarpini CG, Pett MR, Thornton CM, Enright AJ, Nicholson JC, Coleman N, CCLG. Cancer Res; 2013 Aug 01; 73(15):4872-84. PubMed ID: 23774216 [Abstract] [Full Text] [Related]
20. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Shima H, Kida K, Adachi S, Yamada A, Sugae S, Narui K, Miyagi Y, Nishi M, Ryo A, Murata S, Taniguchi H, Ichikawa Y, Ishikawa T, Endo I. Breast Cancer Res Treat; 2018 Aug 01; 170(3):507-516. PubMed ID: 29693231 [Abstract] [Full Text] [Related] Page: [Next] [New Search]